补中益气汤对肝动脉化疗栓塞术后患者疲劳指数和生活质量的影响  

Effects of Buzhong Yiqi decoction on fatigue index and quality of life in patients with primary hepatocellular carcinoma after transarterial chemoembolization

作　　者：唐颖慧 曹新艳 李粉萍 叶苗青 TANG Ying-hui;CAO Xin-yan;LI Fen-ping;YE Miao-qing(Department of Liver diseases,Shaanxi Provincial Hospital of Traditional Chinese Medicine,Xi'an 71003,China;Shanxi University of Traditional Chinese Medicine First School of Clinical Medicine,Xianyang 712046,China)

机构地区：[1]陕西省中医医院肝病科,西安710003 [2]陕西中医药大学第一临床医学院,咸阳712046

出　　处：《中国肿瘤临床与康复》2022年第7期779-781,共3页Chinese Journal of Clinical Oncology and Rehabilitation

基　　金：陕西省中医药管理局中医药科研项目(2021-ZZ-JC035);陕西省中医医院院级课题项目(2020-02)。

摘　　要：目的 探讨补中益气汤对肝动脉化疗栓塞术(TACE)后患者疲劳指数和生活质量的影响。方法 选取2019年10月至2021年5月间陕西省中医医院收治的100例原发性肝癌患者,采用随机数表法分为研究组和对照组,每组50例。两组患者均采用TACE,对照组患者术后采用常规西医对症治疗,研究组患者术后在对照组基础上联合补中益气汤治疗,比较两组患者的疲劳指数、生活质量和治疗效果。结果 治疗前,两组患者的疲劳指数和生活质量比较,差异无统计学意义(P>0.05);治疗后,研究组患者的疲劳指数低于对照组,生活质量评分高于对照组,差异均有统计学意义(均P<0.05)。研究组患者的疾病缓解率为96.0%,高于对照组的80.0%,差异有统计学意义(P<0.05)。结论 原发性肝癌患者在TACE后行补中益气汤治疗,可提升患者的治疗效果,缓解疲劳指数,改善生活质量,建议临床借鉴。Objective To systematically analyze the effects of Buzhong Yiqi decoction on fatigue index and quality of life in patients with primary hepatocellular carcinoma after transarterial chemoembolization(TACE). Methods One hundred patients with primary hepatocellular carcinoma undergoing TACE were selected at Shaanxi Provincial Hospital of Traditional Chinese Medicine from October 2019 to May 2021. They were divided into an experimental group and a control group using the random number method with 50 patients in each group. The experimental group received Buzhong Yiqi decoction besides conventional Western medicine and the control group conventional Western medicine for symptomatic treatment after TACE. Fatigue index, quality of life, and treatment outcomes were compared between the two groups. Results Before the treatment, there was no significant difference in fatigue index and quality of life score between the two groups(P>0.05). After the treatment, compared with the control group, the fatigue index was lower and quality of life score was higher in the experimental group than in the control group(all P<0.05). The remission rate was 96.0% in the experimental group which was higher than 80.0% of the control group(P<0.05). Conclusion Buzhong Yiqi decoction after transarterial chemoembolization(TACE) can significantly improve the therapeutic effect, relieve fatigue index, and improve quality of life in patients with primary hepatocellular carcinoma. It is recommended for further clinical research and reference.

关 键 词：补中益气汤 原发性肝肿瘤 肝动脉化疗栓塞术 疲劳指数 生活质量 

分 类 号：R735.7[医药卫生—肿瘤]